Pub Date : 2026-02-01Epub Date: 2025-08-17DOI: 10.1007/s11255-025-04744-3
Sawera Memon, Ali Hyder, Ekata Agnes Omoijuanfo, Noor Un Nisa Irshad, Adil Mushtaq, Nilay Bhatt
{"title":"Clinical insights on \"Analyzing the association of estimated pulse wave velocity with the risk and mortality of chronic kidney disease: a study based on the NHANES database\".","authors":"Sawera Memon, Ali Hyder, Ekata Agnes Omoijuanfo, Noor Un Nisa Irshad, Adil Mushtaq, Nilay Bhatt","doi":"10.1007/s11255-025-04744-3","DOIUrl":"10.1007/s11255-025-04744-3","url":null,"abstract":"","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"731-732"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-08-17DOI: 10.1007/s11255-025-04735-4
Syeda Asmar Saqib, Ekta Rani, Ali Karim, Noor Un Nisa Irshad, Amisha Kumari, Nilay Bhatt
We comment on the recent study by Fröhlich et al., which evaluated the influence of adherence to multidisciplinary tumor board (MDT) recommendations on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy. While this study contributes valuable real-world data, we highlight several limitations. Notably, psychosocial factors influencing adherence, such as fear of toxicity and socioeconomic concerns, were not addressed. Additionally, selection bias may have influenced the observed benefits of adjuvant radiotherapy, warranting the use of propensity score methods in future analyses. Finally, the lack of improvement in overall survival despite better biochemical recurrence-free survival raises questions about the clinical relevance of surrogate endpoints. We advocate for broader, patient-centered approaches and methodological rigor in future investigations.
{"title":"Clinical insights on \"Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy\".","authors":"Syeda Asmar Saqib, Ekta Rani, Ali Karim, Noor Un Nisa Irshad, Amisha Kumari, Nilay Bhatt","doi":"10.1007/s11255-025-04735-4","DOIUrl":"10.1007/s11255-025-04735-4","url":null,"abstract":"<p><p>We comment on the recent study by Fröhlich et al., which evaluated the influence of adherence to multidisciplinary tumor board (MDT) recommendations on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy. While this study contributes valuable real-world data, we highlight several limitations. Notably, psychosocial factors influencing adherence, such as fear of toxicity and socioeconomic concerns, were not addressed. Additionally, selection bias may have influenced the observed benefits of adjuvant radiotherapy, warranting the use of propensity score methods in future analyses. Finally, the lack of improvement in overall survival despite better biochemical recurrence-free survival raises questions about the clinical relevance of surrogate endpoints. We advocate for broader, patient-centered approaches and methodological rigor in future investigations.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"551-552"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-08-28DOI: 10.1007/s11255-025-04757-y
Mazin M T Shigidi, Nazik M Abdulfatah
Purpose: Henna artists are frequently exposed to para-phenylenediamine (PPD), a common hair dye component, raising concerns about its nephrotoxic effects. This study investigates the association between long-term PPD exposure and chronic kidney disease (CKD) among henna artists in Sudan.
Methods: A cross-sectional study included 138 female henna artists with over 10 years of professional exposure. Clinical assessments, laboratory tests, and kidney biopsies in selected cases were conducted. Data were analyzed using SPSS to compare female artists with and without CKD.
Results: The mean age of participants was 36.4 ± 8.1 years, with 15.8 ± 6.3 years in the profession. CKD was diagnosed in 27 (19.6%) participants, with persistent hematuria in 19 (70.4%), combined hematuria and proteinuria in 8 (29.6%), and elevated creatinine in 5 (18.5%). Kidney biopsies from 23 participants revealed the presence of chronic tubulointerstitial nephritis in 14 (60.9%), focal segmental glomerulosclerosis in 6 (26.1%), and membranoproliferative glomerulonephritis in 3 (13%) participants. CKD was more common among the unmarried (P = 0.033), those with lower education (P = 0.019), those who worked longer hours (P = 0.015), use high-concentration PPD formulations (P < 0.0001), and work in family parlors rather than professional salons (P = 0.023). CKD was also linked to PPD-induced skin reactions (P < 0.05) and the presence of normochromic normocytic anemia (P = 0.024).
Conclusion: This study suggests an association between prolonged PPD exposure and CKD risk among female henna artists. These findings underscore the need for greater awareness and further investigation into PPD's nephrotoxic effects.
{"title":"Long-term para-phenylenediamine exposure and chronic kidney disease risk in adult female henna artists: a cross-sectional study.","authors":"Mazin M T Shigidi, Nazik M Abdulfatah","doi":"10.1007/s11255-025-04757-y","DOIUrl":"10.1007/s11255-025-04757-y","url":null,"abstract":"<p><strong>Purpose: </strong>Henna artists are frequently exposed to para-phenylenediamine (PPD), a common hair dye component, raising concerns about its nephrotoxic effects. This study investigates the association between long-term PPD exposure and chronic kidney disease (CKD) among henna artists in Sudan.</p><p><strong>Methods: </strong>A cross-sectional study included 138 female henna artists with over 10 years of professional exposure. Clinical assessments, laboratory tests, and kidney biopsies in selected cases were conducted. Data were analyzed using SPSS to compare female artists with and without CKD.</p><p><strong>Results: </strong>The mean age of participants was 36.4 ± 8.1 years, with 15.8 ± 6.3 years in the profession. CKD was diagnosed in 27 (19.6%) participants, with persistent hematuria in 19 (70.4%), combined hematuria and proteinuria in 8 (29.6%), and elevated creatinine in 5 (18.5%). Kidney biopsies from 23 participants revealed the presence of chronic tubulointerstitial nephritis in 14 (60.9%), focal segmental glomerulosclerosis in 6 (26.1%), and membranoproliferative glomerulonephritis in 3 (13%) participants. CKD was more common among the unmarried (P = 0.033), those with lower education (P = 0.019), those who worked longer hours (P = 0.015), use high-concentration PPD formulations (P < 0.0001), and work in family parlors rather than professional salons (P = 0.023). CKD was also linked to PPD-induced skin reactions (P < 0.05) and the presence of normochromic normocytic anemia (P = 0.024).</p><p><strong>Conclusion: </strong>This study suggests an association between prolonged PPD exposure and CKD risk among female henna artists. These findings underscore the need for greater awareness and further investigation into PPD's nephrotoxic effects.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"673-679"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144954416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To investigate the association between systemic inflammation and activities of daily living (ADL) in older patients with chronic kidney disease (CKD) in the acute phase.
Methods: This observational, retrospective cohort study included patients with CKD aged 65 years and older with unscheduled admissions to the nephrology department between January 2019 and February 2022. Patients who underwent maintenance hemodialysis therapy; died during hospitalization; were treated in other departments; experienced serious events during hospitalization; or did not receive rehabilitation during hospitalization were excluded. Systemic inflammation was assessed by the modified Glasgow Prognostic Score (mGPS) on admission, and ADL was assessed by functional independence measure (FIM) at discharge.
Results: A total of 89 patients (median age, 80 years [interquartile range, 75-84 years]) were included in the analysis. An mGPS score of 0, 1, and 2 was assigned to 41 (46.1%), 15 (16.9%), and 33 (37.1%) patients, respectively. In multivariable analysis, the mGPS (SE = 2.16; β = - 0.25; P = 0.001) was significantly associated with the FIM score at discharge. On the other hand, albumin (ρ = 0.093; 95% CI, - 0.12 to 0.30; P = 0.384) and CRP level (ρ = - 0.176; 95% CI; - 0.37 to 0.03; P = 0.098) were not significantly correlated with the FIM score at discharge.
Conclusion: Among older patients with CKD in the acute phase, systemic inflammation assessed using the mGPS may be useful for predicting ADL.
{"title":"Systemic inflammation is associated with reduced functional recovery in older inpatients with chronic kidney disease.","authors":"Keita Ohashi, Kentaro Iwata, Kanji Yamada, Yoshihiro Yoshimura, Atsuki Nozaki, Akio Yamamoto, Kumiko Ono, Takeshi Kitai, Akihiro Yoshimoto, Nobuo Kohara, Akira Ishikawa","doi":"10.1007/s11255-025-04721-w","DOIUrl":"10.1007/s11255-025-04721-w","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the association between systemic inflammation and activities of daily living (ADL) in older patients with chronic kidney disease (CKD) in the acute phase.</p><p><strong>Methods: </strong>This observational, retrospective cohort study included patients with CKD aged 65 years and older with unscheduled admissions to the nephrology department between January 2019 and February 2022. Patients who underwent maintenance hemodialysis therapy; died during hospitalization; were treated in other departments; experienced serious events during hospitalization; or did not receive rehabilitation during hospitalization were excluded. Systemic inflammation was assessed by the modified Glasgow Prognostic Score (mGPS) on admission, and ADL was assessed by functional independence measure (FIM) at discharge.</p><p><strong>Results: </strong>A total of 89 patients (median age, 80 years [interquartile range, 75-84 years]) were included in the analysis. An mGPS score of 0, 1, and 2 was assigned to 41 (46.1%), 15 (16.9%), and 33 (37.1%) patients, respectively. In multivariable analysis, the mGPS (SE = 2.16; β = - 0.25; P = 0.001) was significantly associated with the FIM score at discharge. On the other hand, albumin (ρ = 0.093; 95% CI, - 0.12 to 0.30; P = 0.384) and CRP level (ρ = - 0.176; 95% CI; - 0.37 to 0.03; P = 0.098) were not significantly correlated with the FIM score at discharge.</p><p><strong>Conclusion: </strong>Among older patients with CKD in the acute phase, systemic inflammation assessed using the mGPS may be useful for predicting ADL.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"631-638"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144954417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-07-11DOI: 10.1007/s11255-025-04620-0
Benedikt Hoeh, Jeremy Kwe, Fabian Schreiber, Tobias Hölscher, Katharina Boehm, Martin Baunacke, Roman Herout, Christian Thomas, Angelika Borkowetz
Background: In prostate cancer (PCa) patients treated with radical prostatectomy (RP), multidisciplinary tumor boards (MDT) issue recommendations to undergo adjuvant (aRT) or salvage radiotherapy (sRT). However, reliable data regarding the adherence rate to MDT recommendations and subsequently its impact on oncological outcomes are scarce.
Methods: We retrospectively identified patients treated with RP within a certified prostate cancer center between 2012 and 2016, receiving an MDT recommendation to undergo adjuvant or salvage radiotherapy following RP due to adverse pathological features (non-organ confined disease, positive surgical margin, positive lymph node). Patients with a follow-up < 3 years were excluded. Among patients recommended to undergo aRT, adherence rate was calculated. Patients adherent vs. non-adherent to aRT recommendation were compared regarding biochemical recurrence (BCR), PSA failure following aRT or sRT, and cancer-specific (CSS) and overall survival (OS).
Results: Of 802 patients, 408 (51.5%) were recommended to undergo aRT. Among those, 121 (30%) received aRT, whereas 287 (70%) were non-adherent to aRT-MDT recommendation. In multivariable logistic regression models, age, performance status and presence of adverse pathological features represented statistically significant predictors to undergo aRT. Rates of BCR (40.4 vs. 66.6%) as well as subsequent median time of PSA failure following radiotherapy (83 vs. 42 months) favored patients adherent to aRT recommendations (both p < 0.001). No differences were recorded in CSS and OS analyses regarding adherence to aRT recommendations.
Conclusion: Solely a fraction of patients followed the recommendation to undergo aRT. Patients adherent to aRT recommendation demonstrated lower rates of subsequent PCa recurrences, albeit not (yet) translating into CSS/OS differences.
背景:在接受根治性前列腺切除术(RP)治疗的前列腺癌(PCa)患者中,多学科肿瘤委员会(MDT)提出了接受辅助(aRT)或补救性放疗(sRT)的建议。然而,关于MDT建议的依从率及其对肿瘤预后的影响的可靠数据很少。方法:回顾性研究2012年至2016年间在一家认证的前列腺癌中心接受RP治疗的患者,由于不良病理特征(非器官局限性疾病、手术切缘阳性、淋巴结阳性),接受MDT推荐的RP后辅助或补救性放疗。随访结果:802例患者中,408例(51.5%)推荐接受aRT治疗。其中,121人(30%)接受了aRT治疗,而287人(70%)不遵守aRT- mdt建议。在多变量logistic回归模型中,年龄、运动状态和不良病理特征的存在是接受aRT的有统计学意义的预测因素。BCR率(40.4 vs 66.6%)以及放疗后PSA失败的中位时间(83 vs 42个月)有利于坚持aRT建议的患者(两者均为p结论:只有一小部分患者遵循建议接受aRT。坚持aRT推荐的患者显示出较低的PCa复发率,尽管(尚未)转化为CSS/OS差异。
{"title":"Adherence to post-therapeutic multidisciplinary tumor board recommendation and its influence on oncological outcomes in high-risk prostate cancer patients following radical prostatectomy.","authors":"Benedikt Hoeh, Jeremy Kwe, Fabian Schreiber, Tobias Hölscher, Katharina Boehm, Martin Baunacke, Roman Herout, Christian Thomas, Angelika Borkowetz","doi":"10.1007/s11255-025-04620-0","DOIUrl":"10.1007/s11255-025-04620-0","url":null,"abstract":"<p><strong>Background: </strong>In prostate cancer (PCa) patients treated with radical prostatectomy (RP), multidisciplinary tumor boards (MDT) issue recommendations to undergo adjuvant (aRT) or salvage radiotherapy (sRT). However, reliable data regarding the adherence rate to MDT recommendations and subsequently its impact on oncological outcomes are scarce.</p><p><strong>Methods: </strong>We retrospectively identified patients treated with RP within a certified prostate cancer center between 2012 and 2016, receiving an MDT recommendation to undergo adjuvant or salvage radiotherapy following RP due to adverse pathological features (non-organ confined disease, positive surgical margin, positive lymph node). Patients with a follow-up < 3 years were excluded. Among patients recommended to undergo aRT, adherence rate was calculated. Patients adherent vs. non-adherent to aRT recommendation were compared regarding biochemical recurrence (BCR), PSA failure following aRT or sRT, and cancer-specific (CSS) and overall survival (OS).</p><p><strong>Results: </strong>Of 802 patients, 408 (51.5%) were recommended to undergo aRT. Among those, 121 (30%) received aRT, whereas 287 (70%) were non-adherent to aRT-MDT recommendation. In multivariable logistic regression models, age, performance status and presence of adverse pathological features represented statistically significant predictors to undergo aRT. Rates of BCR (40.4 vs. 66.6%) as well as subsequent median time of PSA failure following radiotherapy (83 vs. 42 months) favored patients adherent to aRT recommendations (both p < 0.001). No differences were recorded in CSS and OS analyses regarding adherence to aRT recommendations.</p><p><strong>Conclusion: </strong>Solely a fraction of patients followed the recommendation to undergo aRT. Patients adherent to aRT recommendation demonstrated lower rates of subsequent PCa recurrences, albeit not (yet) translating into CSS/OS differences.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"433-440"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12864311/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144618089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-07-25DOI: 10.1007/s11255-025-04691-z
Tenaw Tiruye, Alex Jay, Michael O'Callaghan, Liesel M FitzGerald, David Roder, Kerri Beckmann
Purpose: Prostate cancer is a common malignancy in men, with radical prostatectomy (RP) being a major treatment option. This study investigates post-prostatectomy rehospitalisation rates and risk factors in a cohort of South Australian men who underwent RP from 2002 to 2021 (n = 5105).
Methods: Post-prostatectomy rehospitalisation rates at 30 and 90 days were measured from hospital discharge data, with reasons determined from ICD-10 codes. Rates per 1000 person-time were estimated, accounting for the length of follow-up. Zero inflated negative binomial regression analyses were used to identify sociodemographic and clinical factors associated with the number of hospital encounters following RP.
Results: Approximately 13% of patients had at least one hospital visit within 90 days post-prostatectomy. Common reasons for early rehospitalisation (within 30 days) were urinary obstruction (3.2%), haematuria (2.6%), and urinary tract infection (2.5%). Older age (aged 75 + vs < 60: incidence rate ratio (IRR) 2.23, 95% CI: 1.88-2.64), highest comorbidity burden (3 + vs 0: IRR 2.33, 95% CI: 1.80-3.01), and high risk clinical characteristics (PSA > 20 vs < 10 ng/mL: IRR 1.67, 95% CI: 1.34-2.08 and Gleason score 9-10 vs < 7: IRR 1.39, 95% CI: 1.06-1.84) were associated with higher rehospitalisation rates. Conversely, men who were treated from 2016-2021 had 39% lower rehospitalisation rates (IRR 0.61, 95% CI: 0.53-0.71) compared with patients treated from 2002-2005.
Conclusion: These findings highlight the importance of considering patient characteristics and tailoring post-surgical care plans to minimise rehospitalisation. The reduction in rehospitalisation over time may reflect advancements in surgical techniques, better patient selection or improved surgeon experience.
{"title":"Post-prostatectomy rehospitalisation rates and risk factors in South Australian men with prostate cancer: evidence from linked data.","authors":"Tenaw Tiruye, Alex Jay, Michael O'Callaghan, Liesel M FitzGerald, David Roder, Kerri Beckmann","doi":"10.1007/s11255-025-04691-z","DOIUrl":"10.1007/s11255-025-04691-z","url":null,"abstract":"<p><strong>Purpose: </strong>Prostate cancer is a common malignancy in men, with radical prostatectomy (RP) being a major treatment option. This study investigates post-prostatectomy rehospitalisation rates and risk factors in a cohort of South Australian men who underwent RP from 2002 to 2021 (n = 5105).</p><p><strong>Methods: </strong>Post-prostatectomy rehospitalisation rates at 30 and 90 days were measured from hospital discharge data, with reasons determined from ICD-10 codes. Rates per 1000 person-time were estimated, accounting for the length of follow-up. Zero inflated negative binomial regression analyses were used to identify sociodemographic and clinical factors associated with the number of hospital encounters following RP.</p><p><strong>Results: </strong>Approximately 13% of patients had at least one hospital visit within 90 days post-prostatectomy. Common reasons for early rehospitalisation (within 30 days) were urinary obstruction (3.2%), haematuria (2.6%), and urinary tract infection (2.5%). Older age (aged 75 + vs < 60: incidence rate ratio (IRR) 2.23, 95% CI: 1.88-2.64), highest comorbidity burden (3 + vs 0: IRR 2.33, 95% CI: 1.80-3.01), and high risk clinical characteristics (PSA > 20 vs < 10 ng/mL: IRR 1.67, 95% CI: 1.34-2.08 and Gleason score 9-10 vs < 7: IRR 1.39, 95% CI: 1.06-1.84) were associated with higher rehospitalisation rates. Conversely, men who were treated from 2016-2021 had 39% lower rehospitalisation rates (IRR 0.61, 95% CI: 0.53-0.71) compared with patients treated from 2002-2005.</p><p><strong>Conclusion: </strong>These findings highlight the importance of considering patient characteristics and tailoring post-surgical care plans to minimise rehospitalisation. The reduction in rehospitalisation over time may reflect advancements in surgical techniques, better patient selection or improved surgeon experience.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"527-536"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12864347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144707482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-07-21DOI: 10.1007/s11255-025-04682-0
Nguyen Vu Le, Minh Phuc Cao, Long Hoang, Quang Nghia Nguyen
Purpose: (i) Describe renal vascular anatomy in Vietnamese donors with 256-slice MSCT; (ii) relate imaging to operative metrics and early outcomes of trans-peritoneal laparoscopic donor nephrectomy (LDN).
Methods: All consecutive living kidney donors who underwent trans-peritoneal LDN at Viet Duc University Hospital between January 2023 and June 2024 were prospectively enrolled. Eligibility required compliance with national donation criteria, informed consent, and complete clinical documentation. MSCT data (vessel number, length, diameter, variants) and surgical variables (trocar use, warm-ischemia time, blood loss, complications) were extracted from electronic records.
Results: 166 donors (41.6 ± 10.2 yr, 59% female) were analyzed. MSCT showed a single renal artery in 77.3% of kidneys and ≥ 2 arteries in 22.7%; multiple veins were more common on the right (14.7%). The left renal vein was far longer than the right (66.0 ± 14.0 vs 25.3 ± 7.4 mm, p < 0.001). Vessel number was predicted correctly in 95.8% of cases although pedicle length was over-estimated by 3-9 mm (p < 0.001). All nephrectomies were completed laparoscopically. Mean operative time was 118 ± 23 min; warm-ischemia time 4.5 ± 1.1 min; blood loss 70 ± 33 mL with no transfusions. Intra-operative morbidity was 4.2% (minor only) and 30-day morbidity 9.6%, almost entirely self-limited lymphatic leaks. Drains were removed after 3.5 ± 0.7 days; donors were discharged after 7.2 ± 2.0 days; creatinine fell from 110 to 92 µmol L⁻1 within one month.
Conclusion: 256-slice MSCT provides highly accurate vascular mapping that correlates closely with intra-operative findings. When combined with trans-peritoneal LDN, it yields short operative times, low complication rates, and rapid donor recovery, supporting its routine use in living donor programs in resource-constrained settings.
目的:(i)用256层MSCT描述越南供体肾血管解剖;(ii)将影像学与经腹膜腹腔镜供体肾切除术(LDN)的手术指标和早期结果联系起来。方法:前瞻性纳入2023年1月至2024年6月期间在越南大学医院接受经腹膜LDN的所有连续活体肾供者。资格要求符合国家捐赠标准,知情同意和完整的临床文件。从电子记录中提取MSCT数据(血管数目、长度、直径、变异)和手术变量(套管针使用、热缺血时间、失血、并发症)。结果:共分析166例献血者(41.6±10.2岁,女性59%)。MSCT显示77.3%的肾脏有单一肾动脉,22.7%的肾脏有≥2条肾动脉;右侧多静脉多见(14.7%)。左肾静脉远长于右肾静脉(66.0±14.0 vs 25.3±7.4 mm, 1个月内p < 0.01)。结论:256层MSCT提供了高度精确的血管定位,与术中发现密切相关。当与经腹膜LDN联合使用时,手术时间短,并发症发生率低,供体恢复迅速,支持其在资源受限环境下活体供体计划中的常规使用。
{"title":"Outcomes of transperitoneal laparoscopic living donor nephrectomy: a single-center study in Vietnam.","authors":"Nguyen Vu Le, Minh Phuc Cao, Long Hoang, Quang Nghia Nguyen","doi":"10.1007/s11255-025-04682-0","DOIUrl":"10.1007/s11255-025-04682-0","url":null,"abstract":"<p><strong>Purpose: </strong>(i) Describe renal vascular anatomy in Vietnamese donors with 256-slice MSCT; (ii) relate imaging to operative metrics and early outcomes of trans-peritoneal laparoscopic donor nephrectomy (LDN).</p><p><strong>Methods: </strong>All consecutive living kidney donors who underwent trans-peritoneal LDN at Viet Duc University Hospital between January 2023 and June 2024 were prospectively enrolled. Eligibility required compliance with national donation criteria, informed consent, and complete clinical documentation. MSCT data (vessel number, length, diameter, variants) and surgical variables (trocar use, warm-ischemia time, blood loss, complications) were extracted from electronic records.</p><p><strong>Results: </strong>166 donors (41.6 ± 10.2 yr, 59% female) were analyzed. MSCT showed a single renal artery in 77.3% of kidneys and ≥ 2 arteries in 22.7%; multiple veins were more common on the right (14.7%). The left renal vein was far longer than the right (66.0 ± 14.0 vs 25.3 ± 7.4 mm, p < 0.001). Vessel number was predicted correctly in 95.8% of cases although pedicle length was over-estimated by 3-9 mm (p < 0.001). All nephrectomies were completed laparoscopically. Mean operative time was 118 ± 23 min; warm-ischemia time 4.5 ± 1.1 min; blood loss 70 ± 33 mL with no transfusions. Intra-operative morbidity was 4.2% (minor only) and 30-day morbidity 9.6%, almost entirely self-limited lymphatic leaks. Drains were removed after 3.5 ± 0.7 days; donors were discharged after 7.2 ± 2.0 days; creatinine fell from 110 to 92 µmol L⁻<sup>1</sup> within one month.</p><p><strong>Conclusion: </strong>256-slice MSCT provides highly accurate vascular mapping that correlates closely with intra-operative findings. When combined with trans-peritoneal LDN, it yields short operative times, low complication rates, and rapid donor recovery, supporting its routine use in living donor programs in resource-constrained settings.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"477-482"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144674763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-07-23DOI: 10.1007/s11255-025-04677-x
Xingyang Su, Feng Chen, Zeyu Shi, Yifang Tao, Xiujuan Han, Li Xue
Purpose: Globally, epidemiological data on sex chromosomal disorders of sex development (DSDs) remain scarce, prompting this study to examine their global disease burden and health inequalities, with a focus on Klinefelter syndrome (KS) and Turner syndrome (TS).
Methods: We collected data on the incidence and prevalence of KS and TS from the GBD 2021 and analyzed by location, age, and socio-demographic index (SDI), using estimated annual percentage changes, Spearman's correlation analysis, health inequality analysis, and Bayesian age-period-cohort prediction models. The slope index of inequality and concentration index were employed to assess absolute and relative health inequalities across countries with varying SDI levels.
Results: In 2021, there were 68,357 incident cases of KS with an incidence rate of 102.12, and the prevalent cases reached 1,121,754, with an age-standardized prevalence rate (ASPR) of 29.68. For TS, there were 23,929 incident cases, with an incidence rate of 38.32, and 531,784 prevalent cases, with an ASPR of 14.47. The ASPR of KS showed an upward trend, while that of TS exhibited a downward trend. The prevalence of DSDs declined with age, most notably in the 0-9 age groups, with the slowest decline observed in high SDI regions. The highest incidence rate was in Sub-Saharan Africa, while the most significant growth was concentrated in Europe. Correlation analysis revealed a negative association or "U-shaped" relationship between the incidence rate of sex chromosomal DSDs and SDI. Inequality analysis indicated that low SDI countries bear a disproportionate burden, with SDI-related inequalities worsening over time, particularly in incidence rates. The burden of KS is forecast to grow modestly by 2036, contrasting with TS's expected gradual decline.
Conclusions: Globally, KS has shown increasing impact among sex chromosomal DSDs, contrasting with TS. Persistent disparities across SDI regions highlight urgent needs for enhanced screening and long-term care in low SDI areas to reduce inequalities.
{"title":"Global burden and health inequalities of sex chromosomal DSDs (1990-2021): a GBD 2021 analysis.","authors":"Xingyang Su, Feng Chen, Zeyu Shi, Yifang Tao, Xiujuan Han, Li Xue","doi":"10.1007/s11255-025-04677-x","DOIUrl":"10.1007/s11255-025-04677-x","url":null,"abstract":"<p><strong>Purpose: </strong>Globally, epidemiological data on sex chromosomal disorders of sex development (DSDs) remain scarce, prompting this study to examine their global disease burden and health inequalities, with a focus on Klinefelter syndrome (KS) and Turner syndrome (TS).</p><p><strong>Methods: </strong>We collected data on the incidence and prevalence of KS and TS from the GBD 2021 and analyzed by location, age, and socio-demographic index (SDI), using estimated annual percentage changes, Spearman's correlation analysis, health inequality analysis, and Bayesian age-period-cohort prediction models. The slope index of inequality and concentration index were employed to assess absolute and relative health inequalities across countries with varying SDI levels.</p><p><strong>Results: </strong>In 2021, there were 68,357 incident cases of KS with an incidence rate of 102.12, and the prevalent cases reached 1,121,754, with an age-standardized prevalence rate (ASPR) of 29.68. For TS, there were 23,929 incident cases, with an incidence rate of 38.32, and 531,784 prevalent cases, with an ASPR of 14.47. The ASPR of KS showed an upward trend, while that of TS exhibited a downward trend. The prevalence of DSDs declined with age, most notably in the 0-9 age groups, with the slowest decline observed in high SDI regions. The highest incidence rate was in Sub-Saharan Africa, while the most significant growth was concentrated in Europe. Correlation analysis revealed a negative association or \"U-shaped\" relationship between the incidence rate of sex chromosomal DSDs and SDI. Inequality analysis indicated that low SDI countries bear a disproportionate burden, with SDI-related inequalities worsening over time, particularly in incidence rates. The burden of KS is forecast to grow modestly by 2036, contrasting with TS's expected gradual decline.</p><p><strong>Conclusions: </strong>Globally, KS has shown increasing impact among sex chromosomal DSDs, contrasting with TS. Persistent disparities across SDI regions highlight urgent needs for enhanced screening and long-term care in low SDI areas to reduce inequalities.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"483-499"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144690191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-07-11DOI: 10.1007/s11255-025-04648-2
Benjamin M Mac Curtain, Behzad Abbasi, Lynn Leng, Ankith Maremanda, Marvin Carlisle, Nizar Hakam, Kevin Li, Anna Faris, Mikołaj Frankiewicz, Benjamin N Breyer
Purpose: To systematically evaluate the incidence of bladder neck contracture (BNC) following surgical treatments for benign prostate hyperplasia (BPH).
Methods: A systematic search of PubMed, Embase, and CENTRAL was conducted to identify randomized, prospective trials reporting BNC following BPH surgery up to October 29, 2024. Eligible studies included adults, compared two surgical methods, and had at least two years of follow-up, to ensure adequate time for BNC development. Proportions were pooled and risk ratios were produced using random effects models.
Results: Eleven studies comprising 1,536 patients with 2-year follow-up were included. The pooled incidence of BNC following all included BPH surgeries was 3% (95% CI 2-5). The BNC rate was 9% (95% CI 4-15) for photosensitive photo-selective vaporization of the prostate (PVP), 3% (95% CI 2-5) for transurethral resection of the prostate (TURP), and 3% (95% CI 1-5) for holmium laser enucleation of the prostate (HoLEP). TURP and HoLEP were not associated with an increased risk of BNC compared to alternative treatments including transurethral incision of the prostate, HoLEP, PVP, thulium laser resection of the prostate, diode laser vaporization of the prostate or laparoscopic simple prostatectomy for TURP, and TURP, open prostatectomy, and bipolar enucleation of the prostate for HoLEP. We observed log risk ratios, regarding BNC formation, of 0.19 (95% CI - 0.70 to 1.08) and - 0.34 (95% CI - 1.41 to 0.73), for TURP and HoLEP, respectively. Smaller prostate size and anticoagulant use were linked to BNC formation. The preferred treatment for BNC was bladder neck/prostate incision or re-resection.
Conclusions: BNC is a relatively uncommon complication following surgical treatment for BPH. HoLEP and TURP are not associated with an increased risk of BNC compared to other methods of surgical treatment, while smaller prostate size may be a potential risk factor. Further research is needed to identify modifiable factors and assess outcomes of emerging treatments.
目的:系统评价良性前列腺增生(BPH)手术后膀胱颈挛缩(BNC)的发生率。方法:对PubMed、Embase和CENTRAL进行系统检索,以确定截至2024年10月29日报告BPH手术后BNC的随机前瞻性试验。符合条件的研究包括成人,比较两种手术方法,并进行至少两年的随访,以确保有足够的时间进行BNC发育。比例汇总,风险比使用随机效应模型产生。结果:纳入11项研究,1536例患者,随访2年。所有BPH手术后BNC的总发生率为3% (95% CI 2-5)。前列腺光敏光选择性汽化术(PVP)的BNC率为9% (95% CI 4-15),经尿道前列腺切除术(TURP)的BNC率为3% (95% CI 2-5),钬激光前列腺摘除(HoLEP)的BNC率为3% (95% CI 1-5)。与经尿道前列腺切开、HoLEP、PVP、铥激光前列腺切除术、二极管激光前列腺汽化或腹腔镜简单前列腺切除术、TURP、开放式前列腺切除术和HoLEP双极前列腺切除术等替代治疗相比,TURP和HoLEP与BNC风险增加无关。我们观察到,对于TURP和HoLEP,关于BNC形成的对数风险比分别为0.19 (95% CI - 0.70至1.08)和- 0.34 (95% CI - 1.41至0.73)。较小的前列腺大小和抗凝剂的使用与BNC的形成有关。BNC的首选治疗方法是膀胱颈部/前列腺切开或再切除。结论:BNC是前列腺增生手术治疗后较少见的并发症。与其他手术治疗方法相比,HoLEP和TURP与BNC风险增加无关,而前列腺体积较小可能是一个潜在的危险因素。需要进一步的研究来确定可改变的因素并评估新兴治疗方法的结果。
{"title":"Bladder neck contracture post-treatment for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized clinical studies.","authors":"Benjamin M Mac Curtain, Behzad Abbasi, Lynn Leng, Ankith Maremanda, Marvin Carlisle, Nizar Hakam, Kevin Li, Anna Faris, Mikołaj Frankiewicz, Benjamin N Breyer","doi":"10.1007/s11255-025-04648-2","DOIUrl":"10.1007/s11255-025-04648-2","url":null,"abstract":"<p><strong>Purpose: </strong>To systematically evaluate the incidence of bladder neck contracture (BNC) following surgical treatments for benign prostate hyperplasia (BPH).</p><p><strong>Methods: </strong>A systematic search of PubMed, Embase, and CENTRAL was conducted to identify randomized, prospective trials reporting BNC following BPH surgery up to October 29, 2024. Eligible studies included adults, compared two surgical methods, and had at least two years of follow-up, to ensure adequate time for BNC development. Proportions were pooled and risk ratios were produced using random effects models.</p><p><strong>Results: </strong>Eleven studies comprising 1,536 patients with 2-year follow-up were included. The pooled incidence of BNC following all included BPH surgeries was 3% (95% CI 2-5). The BNC rate was 9% (95% CI 4-15) for photosensitive photo-selective vaporization of the prostate (PVP), 3% (95% CI 2-5) for transurethral resection of the prostate (TURP), and 3% (95% CI 1-5) for holmium laser enucleation of the prostate (HoLEP). TURP and HoLEP were not associated with an increased risk of BNC compared to alternative treatments including transurethral incision of the prostate, HoLEP, PVP, thulium laser resection of the prostate, diode laser vaporization of the prostate or laparoscopic simple prostatectomy for TURP, and TURP, open prostatectomy, and bipolar enucleation of the prostate for HoLEP. We observed log risk ratios, regarding BNC formation, of 0.19 (95% CI - 0.70 to 1.08) and - 0.34 (95% CI - 1.41 to 0.73), for TURP and HoLEP, respectively. Smaller prostate size and anticoagulant use were linked to BNC formation. The preferred treatment for BNC was bladder neck/prostate incision or re-resection.</p><p><strong>Conclusions: </strong>BNC is a relatively uncommon complication following surgical treatment for BPH. HoLEP and TURP are not associated with an increased risk of BNC compared to other methods of surgical treatment, while smaller prostate size may be a potential risk factor. Further research is needed to identify modifiable factors and assess outcomes of emerging treatments.</p>","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"369-379"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144608360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-01Epub Date: 2025-08-17DOI: 10.1007/s11255-025-04739-0
Yixin Tian
{"title":"Beyond the index: unpacking CVAI's role in cardio-renal-metabolic risk.","authors":"Yixin Tian","doi":"10.1007/s11255-025-04739-0","DOIUrl":"10.1007/s11255-025-04739-0","url":null,"abstract":"","PeriodicalId":14454,"journal":{"name":"International Urology and Nephrology","volume":" ","pages":"727-728"},"PeriodicalIF":1.9,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144862169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}